Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periorbitally Injected Glucocorticoids for Mild TAO
NCT04548284Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- May 2021
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in thyroid associated ophthalmopathy (TAO) (2 arms), sponsored by Sun Yat-sen University. Primary endpoints: Clinical Activity Score at 12 months and NOSPECS Score at 12 months. Status: unknown.
02
Conditions
thyroid associated ophthalmopathy (TAO)
Beyond the preview
Go deeper on NCT04548284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04548284.